Literature DB >> 29799925

Assessment of Clinical and Social Characteristics That Distinguish Presbylaryngis From Pathologic Presbyphonia in Elderly Individuals.

Brianna K Crawley1, Salem Dehom2, Cedric Thiel3, Jin Yang3, Andrea Cragoe3, Iman Mousselli4, Priya Krishna1, Thomas Murry1.   

Abstract

Importance: An aging population experiences an increase in age-related problems, such as presbyphonia. The causes of pathologic presbyphonia are incompletely understood. Objective: To determine what distinguishes pathologic presbyphonia from presbylaryngis. Design, Setting, and Participants: This was a cohort study at an outpatient otolaryngology subspecialty clinic of a tertiary academic referral center. Participants were consecutive consenting adults older than 74 years without laryngeal pathologic abnormalities who visited the clinic as participants or companions. Patient questionnaires, otolaryngologic, video stroboscopic, and voice examinations were compiled. Patients were divided into groups based on whether they endorsed a voice complaint. Three blinded authors graded stroboscopic examinations for findings consistent with presbylaryngis (vocal fold bowing, vocal process prominence, glottic insufficiency). Main Outcomes and Measures: Voice Handicap Index-10, Reflux Symptom Index, Cough Severity Index, Dyspnea Index, Singing Voice Handicap Index-10 , Eating Assessment Tool -10, Voice-Related Quality of Life (VRQOL), and Short-Form Health Survey; face-sheet addressing social situation, work, marital status, education, voice use, transportation; acoustic and aerodynamic measures; and a full otolaryngologic examination, including videostroboscopic imaging.
Results: A total of 31 participants with dysphonia (21 were female; their mean age was 83 years [range, 75-97 years]) and 26 control participants (16 were female; their mean age was 81 years [range, 75-103 years]) completed the study. Presbylaryngis was visible in 27 patients with dysphonia (87%) and 22 controls (85%). VHI-10 and VRQOL scores were worse in patients with pathologic presbyphonia (median [range] VHI-10 scores, 15 (0-40) vs 0 (0-16) and median VRQOL score, 19 [0-43] vs 10 [10-23]). All other survey results were indistinguishable, and no social differences were elucidated. Acoustic measures revealed that both groups averaged lower than normal speaking fundamental frequency (mean [SD], 150.01 [36.23] vs 150.85 [38.00]). Jitter was 3.44% (95% CI, 2.46%-4.61%) for pathologic presbyphonia and 1.74% (95% CI, 1.35%-2.14%) for controls (d = 0.75). Shimmer means (95% CI) were 7.8 2 (6.08-10.06) for the pathologic presbyphonia group and 4.84 (3.94-5.72) for controls (d = 0.69). Aerodynamic measures revealed an odds ratio of 3.03 (95% CI, 0.83-11.04) for patients with a maximum phonation time of less than 12 seconds who had complaints about dysphonia. Conclusions and Relevance: Presbylaryngis is present in most ambulatory people older than 74 years. Some will endorse pathologic presbyphonia that has a negative effect on their voice and quality of life. Pathologic presbyphonia seems to be influenced by respiratory capacity and sex. Further study is required to isolate other social, physiologic, and general health characteristics that contribute to pathologic presbyphonia.

Entities:  

Mesh:

Year:  2018        PMID: 29799925      PMCID: PMC6583846          DOI: 10.1001/jamaoto.2018.0409

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  30 in total

1.  Morphological and functional aspects of the senile larynx.

Authors:  Paulo Pontes; Rosiane Yamasaki; Mara Behlau
Journal:  Folia Phoniatr Logop       Date:  2006       Impact factor: 0.849

2.  The sound of senescence.

Authors:  S E Linville
Journal:  J Voice       Date:  1996-06       Impact factor: 2.009

Review 3.  Prevalence of voice disorders in the elderly: a systematic review of population-based studies.

Authors:  Leandro de Araújo Pernambuco; Albert Espelt; Patrícia Maria Mendes Balata; Kenio Costa de Lima
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-08-23       Impact factor: 2.503

4.  Development and validation of the Dyspnea Index (DI): a severity index for upper airway-related dyspnea.

Authors:  Jackie L Gartner-Schmidt; Adrianna C Shembel; Thomas G Zullo; Clark A Rosen
Journal:  J Voice       Date:  2014-10-12       Impact factor: 2.009

5.  Prevalence of perceived dysphonia in a geriatric population.

Authors:  Justin S Golub; Po-Hung Chen; Kristen J Otto; Edie Hapner; Michael M Johns
Journal:  J Am Geriatr Soc       Date:  2006-11       Impact factor: 5.562

6.  Development and validation of the Singing Voice Handicap-10.

Authors:  Seth M Cohen; Melissa Statham; Clark A Rosen; Thomas Zullo
Journal:  Laryngoscope       Date:  2009-09       Impact factor: 3.325

7.  Development and validation of the voice handicap index-10.

Authors:  Clark A Rosen; Annie S Lee; Jamie Osborne; Thomas Zullo; Thomas Murry
Journal:  Laryngoscope       Date:  2004-09       Impact factor: 3.325

8.  Dysphonia in the aging: physiology versus disease.

Authors:  P Woo; J Casper; R Colton; D Brewer
Journal:  Laryngoscope       Date:  1992-02       Impact factor: 3.325

9.  Clinical Assessment of Glottal Insufficiency in Age-related Dysphonia.

Authors:  Miguel Vaca; Ignacio Cobeta; Elena Mora; Pablo Reyes
Journal:  J Voice       Date:  2016-01-21       Impact factor: 2.009

10.  Variations of jitter and shimmer among women in menacme and postmenopausal women.

Authors:  Janaína Mendes Laureano; Marcos Felipe S Sá; Rui A Ferriani; Gustavo S Romao
Journal:  J Voice       Date:  2008-12-25       Impact factor: 2.009

View more
  2 in total

1.  Five-year results of vocal fold augmentation using autologous fat or calcium hydroxylapatite.

Authors:  Karol Zeleník; Martin Formánek; Radana Walderová; Debora Formánková; Pavel Komínek
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-11-23       Impact factor: 2.503

2.  Proteomic Characterization of Senescent Laryngeal Adductor and Plantaris Hindlimb Muscles.

Authors:  Adrianna C Shembel; Evgeny Kanshin; Beatrix Ueberheide; Aaron M Johnson
Journal:  Laryngoscope       Date:  2021-06-11       Impact factor: 2.970

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.